Alembic Pharma gets USFDA nod to market generic antidepressant drug

The company's product is therapeutically equivalent to Otsuka Pharmaceutical Co's reference listed drug product Rexulti tablets, it added. Brexpiprazole tablets are indicated as an adjunctive therapy to antidepressants for the treatment of major depressive disorder and for the treatment of schizophrenia.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news